Image_1_Does Combination Therapy With SGLT2 Inhibitors and Renin–Angiotensin System Blockers Lead to Greater Reduction in Cardiorenal Events Among Pat.JPEG (768.92 kB)
Image_1_Does Combination Therapy With SGLT2 Inhibitors and Renin–Angiotensin System Blockers Lead to Greater Reduction in Cardiorenal Events Among Patients With Type 2 Diabetes?.JPEG
figure
posted on 2021-05-05, 04:26 authored by Li-Min Zhao, Miao Zhang, Ze-Lin Zhan, Mei QiuThe full text of this article can be freely accessed on the publisher's website.
